Exact Sciences Corporation logo

Exact Sciences Corporation

EXAS

Financial Statements

Income Statement (Annual)

Amounts in millions

2024

12/31/2024

Revenue
2,759
Cost of Revenue
840
Gross Profit
1,919
Gross Margin
69.5%
Operating Income
-1,049
Operating Margin
-38.0%
Net Income
-1,029
Net Margin
-37.3%
EPS (Basic)
$-5.59
EPS (Diluted)
$-5.59
EBITDA
-789
EBITDA Margin
-28.6%

2023

12/31/2023

Revenue
2,500
Cost of Revenue
738
Gross Profit
1,762
Gross Margin
70.5%
Operating Income
-215
Operating Margin
-8.6%
Net Income
-204
Net Margin
-8.2%
EPS (Basic)
$-1.13
EPS (Diluted)
$-1.13
EBITDA
29
EBITDA Margin
1.2%

2022

12/31/2022

Revenue
2,084
Cost of Revenue
661
Gross Profit
1,423
Gross Margin
68.3%
Operating Income
-594
Operating Margin
-28.5%
Net Income
-624
Net Margin
-29.9%
EPS (Basic)
$-3.54
EPS (Diluted)
$-3.54
EBITDA
-421
EBITDA Margin
-20.2%

2021

12/31/2021

Revenue
1,767
Cost of Revenue
459
Gross Profit
1,308
Gross Margin
74.0%
Operating Income
-856
Operating Margin
-48.4%
Net Income
-596
Net Margin
-33.7%
EPS (Basic)
$-3.48
EPS (Diluted)
$-3.48
EBITDA
-649
EBITDA Margin
-36.7%

2020

12/31/2020

Revenue
1,491
Cost of Revenue
354
Gross Profit
1,137
Gross Margin
76.2%
Operating Income
-768
Operating Margin
-51.5%
Net Income
-824
Net Margin
-55.2%
EPS (Basic)
$-5.45
EPS (Diluted)
$-5.45
EBITDA
-654
EBITDA Margin
-43.8%